Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
GLP-1 medications are a newer class of weight loss treatments
All research and testing is to be completed by an experienced, knowledgeable, and authorized under the appropriate regulatory body and/or licensed researcher in accordance with any and all statutory or regulatory laws in existence at the time of sale or thereafter
Can I File a Lawsuit for Health Problems Related to GLP-1 Drugs
Many patients lose meaningful weight
What should I do if I miss a weekly dose during the dose schedule